Company Filing History:
Years Active: 2025
Title: Innovations of Tingkai Chen in Alzheimer's Disease Treatment
Introduction
Tingkai Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. His innovative work focuses on developing selective inhibitors that can potentially improve the quality of life for patients suffering from this debilitating condition.
Latest Patents
Tingkai Chen holds a patent for a selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof. The patent outlines a preparation method and the use of this inhibitor in treating Alzheimer's disease. The invention demonstrates good target activity in vitro, extremely high selectivity, and drug safety. It serves as a promising lead substance for further development in the treatment of moderate to severe Alzheimer's disease.
Career Highlights
Tingkai Chen is affiliated with China Pharmaceutical University, where he continues to engage in research and development. His work has garnered attention for its potential impact on Alzheimer's treatment, showcasing his dedication to advancing medical science.
Collaborations
Tingkai Chen collaborates with esteemed colleagues, including Haopeng Sun and Hongyu Yang. Their combined expertise contributes to the innovative research being conducted at China Pharmaceutical University.
Conclusion
Tingkai Chen's contributions to the field of Alzheimer's disease treatment through his innovative patent highlight the importance of targeted therapies in modern medicine. His work exemplifies the potential for scientific advancements to improve patient outcomes.